Inverse agonism at adrenergic and opioid receptors: Studies with wild type and constitutively active mutant receptors

Receptors and Channels

Volumn 5, Issue 3-4, 1997, Pages 209-213

  Milligan, G ^a   MacEwan, D J ^a,b   Mercouris, M ^a   Mullaney, I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adrenaline; Constitutively active mutant; G protein; Inverse agonist; Opioid

Indexed keywords

ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETAXOLOL; DELTA OPIATE RECEPTOR; ENZYME INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATASE; MUTANT PROTEIN; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; OPIATE RECEPTOR; PERTUSSIS TOXIN; SOTALOL;

ANIMAL CELL; CELL CLONE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REVIEW;

ANIMALIA; MURINAE;

EID: 0031391110     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Adie EJ and Milligan G (1994) Biochem J 303 803-808
2. Claude PA Wotta DR Zhang XH Prather PL McGinn TM Erickson LJ Loh HH and Law PY (1996) Proc Natl Acad Sci 93 5715-5719
3. Collins S Caron MG and Lefkowitz RJ (1992) Trends Biochem Sci 17 37-39
4. Costa T and Herz A (1989) Proc Natl Acad Sci 86 7321-7325
5. Desaubry L Shoshani I and Johnson RA (1996) J Biol Chem 271 2380-2382
6. Hadcock JR and Malbon CC (1991) Trends Neurosci 14 242-247
7. Johnson RA Yeung SMH Stubner D Bushfield M and Shoshani I (1989) Mol Pharmacol 35 681-688
8. Kjelsberg MA Cotecchia S Ostrowski J Caron MG and Lefkowitz RJ (1992) J Biol Chem 267 1430-1433
9. Konopka JB Margarit SM and Dube P (1996) Proc Natl Acad Sci 93 6764-6769
10. Labrecque J Fargin A Bouvier M Chidiac P and Dennis M (1995) Mol Pharmacol 48 150-159
11. Lefkowitz RJ Cotecchia S Samama P and Costa T (1993) Trends Pharmacol Sci 14 303-307
12. MacEwan DJ and Milligan G (1996) Mol Pharmacol. (in press)
13. MacEwan DJ Kim GD and Milligan G (1996) Biochem J 318 1033-1039
14. Milligan G (1996) Cell Signalling 8 87-96
15. Milligan G Carr C Gould GW Mullaney I and Lavan BE (1991) J Biol Chem 266 6447-6455
16. Milligan G Bond RA and Lee M (1995) Trends Pharmacol Sci 16 10-13
17. Mullaney I Carr IC and Milligan G (1996) Biochem. J. 315 227-234
18. Parma J Duprez L Van Sande J Cochaux P Gervy C Mokel J Dumont J and Vassart G (1993) Nature 365 649-651
19. Pei G Samama P Lohse M Wang M Codina J and Lefkowitz RJ (1994) Proc Natl Acad Sci USA 91 2699-2702
20. Perez DM Hwa J Gaivin R Mathui M Brown F and Graham RM (1996) Mol Pharmacol 49 112-122
21. Ren Q Kurose H Lefkowitz RJ and Cotecchia S (1993) J Biol Chem 268 16483-16487
22. Robinson P Cohen G Zhukovsky E and Oprian D (1992) Neuron 9 719-725
23. Samama P Cotecchia S Costa T and Lefkowitz RJ (1993) J Biol Chem 268 4625-4636
24. Scheer A Fanelli F Costa T De Benedetti PG and Cotecchia S (1996) EMBO J 15 3566-3578
25. Schipani E Kruse K and Juppner H (1995) Science 268 98-100
26. Shenker A Louisa L Kosugi S Merendino J Jr Minegishi T and Cutler G Jr (1993) Nature 365 652-654
27. Smit MJ, Leurs R Alewijnse AE Blauw J Van Nieuw Amerongen GP Van De Vrede Y Roovers E and Timmerman H (1996) Proc Natl Acad Sci 93 6802-6807
28. Tiberi M and Caron MG (1994) J Biol Chem 269 27925-27931